The Stockholm Stock Exchange ended the week with a gain, extending its winning streak to trade up for the eighth day in a row. The trend is in line with that of leading European stock exchanges. The big focus of the day was the Apotea IPO.

At the close, the OMXS30 index was up 0.31 percent to 2,614.27. Shares worth around SEK 15.3 billion were traded on the Stockholm Stock Exchange.

The best performance among the stock exchange's major industrial sectors was real estate with a rise of 1.6 percent. At the other end of the scale, energy was at the bottom with minus 1.8 percent.

Among the leading shares, which are included in the OMXS30 index, Electrolux rose 4.6 percent while Sinch was up 2.9 percent. Boliden was the worst performer, down 3.3%, while Nordea was down 2.0%.

Online pharmacy Apotea began trading on Nasdaq Stockholm today. The share is traded in the Midcap segment with the ticker APOTEA. The subscription price was set at SEK 58 per share, which corresponds to a market capitalization of all shares of SEK 6,036 million. The share gained over 90,000 shareholders in connection with the listing. The share price rose 44.8 percent.

Private equity firm EQT is looking for a buyer for payment services company Banking Circle, a deal that could raise between USD 3-4 billion, equivalent to SEK 32.6-43.5 billion. Bloomberg News reports this with reference to sources. The stock fell 0.2 percent.

Medical technology company Paxman's founder Glenn Paxman, Cimon Venture Trust (represented by chairman Per-Anders Johansson, and board members Björn Littorin and Robert Kelly, have together sold 2 million shares, equivalent to 10.5 percent of the capital, through a placement. Paxman fell 11 percent.

A major shareholder has also sold shares in Eastnine. Warsaw Unit, a subsidiary of real estate investor Ghelamco Group, has sold 7.1 million shares through a placement. The stock fell 3.4 percent.

On the analysis front, Affärsvärlden advises Eyeon to sell and warns that the value will eventually go to zero. The share fell 30.1 percent.

Affärsvärlden switches to a neutral advice for Apotea after the stock market rush.

SEB initiates coverage of Troax with a buy recommendation. The share rose 4.8 percent.

RBC believes that lower copper and zinc prices will hit mining company Boliden in the coming years. The recommendation is lowered to underperform from sector perform, and the target price is lowered to SEK 290 310.

Linc rose 4.8 percent after SEB raised its recommendation to buy from hold.

Nordea raises Trelleborg to buy from hold, and the share rose 4.6 percent.

Carnegie raises its recommendation for Volati to buy from keep, and the share rose 5.5 percent.